These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15384242

  • 1. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA.
    Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
    [Abstract] [Full Text] [Related]

  • 2. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC, Forsmark C, Lew EA, Starr JA, Soffer EF, Bochenek W, Pisegna JR.
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [Abstract] [Full Text] [Related]

  • 3. Proton pump inhibitors and gastric acid secretion.
    Wolfe MM, Welage LS, Sachs G.
    Am J Gastroenterol; 2001 Dec; 96(12):3467-8. PubMed ID: 11774990
    [No Abstract] [Full Text] [Related]

  • 4. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M.
    Rev Prat; 2001 Apr 15; 51(7):789-95. PubMed ID: 11387678
    [No Abstract] [Full Text] [Related]

  • 5. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC.
    Am J Manag Care; 2000 Aug 15; 6(8):934-5. PubMed ID: 11186505
    [No Abstract] [Full Text] [Related]

  • 6. Less acid + less bleeding = better outcomes and more money!
    Enns R.
    Can J Gastroenterol; 2004 Dec 15; 18(12):747-8; discussion 748. PubMed ID: 15605140
    [No Abstract] [Full Text] [Related]

  • 7. [Proton pump inhibitors in acute ulcer bleeding--what is evident?].
    Bohle W, Zoller WG.
    Dtsch Med Wochenschr; 2000 Dec 22; 125(51-52):1571-4. PubMed ID: 11199449
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
    Huggins RM, Scates AC, Latour JK.
    Ann Pharmacother; 2003 Mar 22; 37(3):433-7. PubMed ID: 12639176
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors: an update.
    Vanderhoff BT, Tahboub RM.
    Am Fam Physician; 2002 Jul 15; 66(2):273-80. PubMed ID: 12152963
    [Abstract] [Full Text] [Related]

  • 10. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?
    Guda NM, Noonan M, Kreiner MJ, Partington S, Vakil N.
    Am J Gastroenterol; 2004 Jul 15; 99(7):1233-7. PubMed ID: 15233659
    [Abstract] [Full Text] [Related]

  • 11. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A, Mignon M, Samoyeau R.
    Gastroenterol Clin Biol; 2002 Apr 15; 26(4):355-9. PubMed ID: 12070410
    [Abstract] [Full Text] [Related]

  • 12. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T, Kawashima J, Ariyama S, Kani K, Takabayashi H, Ohno S, Kato S, Yakabi K.
    Dig Endosc; 2012 Mar 15; 24(2):93-9. PubMed ID: 22348833
    [Abstract] [Full Text] [Related]

  • 13. [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].
    Bustamante Baléna M, Ponce García J.
    Rev Clin Esp; 2004 Mar 15; 204(3):161-8. PubMed ID: 15025985
    [No Abstract] [Full Text] [Related]

  • 14. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec 15; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 15. Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.
    McGowan B, Bennett K, Tilson L, Barry M.
    Ir Med J; 2005 Mar 15; 98(3):78-80. PubMed ID: 15869064
    [Abstract] [Full Text] [Related]

  • 16. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM, Gerrity MS, Anderson T.
    Eff Clin Pract; 2001 Mar 15; 4(6):263-70. PubMed ID: 11769299
    [Abstract] [Full Text] [Related]

  • 17. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM, Pace SC, Soffer E, Comer GM, 315 Study Group.
    Am J Gastroenterol; 2006 Sep 15; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [Abstract] [Full Text] [Related]

  • 18. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Sep 15; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 19. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC.
    Digestion; 2000 Sep 15; 62(2-3):73-81. PubMed ID: 11025353
    [Abstract] [Full Text] [Related]

  • 20. [Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole].
    García González F, Soler Company E, Hedo Aparicio G.
    Farm Hosp; 2003 Sep 15; 27(6):339-45. PubMed ID: 14974879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.